Published: 2019-11-21   Views: 29
Author: Amanjaiswar
Published in: Business

Transparency Market Research has published a new report on the systemic inflammatory response syndrome (SIRS) treatment market. According to the report, the global systemic inflammatory response syndrome treatment market was valued at ~US$ 9.3 Bn in 2018, and is projected to expand at a CAGR of ~8% from 2019 to 2027.

Systemic inflammatory response syndrome (SIRS) is defined as a clinical response to a nonspecific onslaught of either infectious or noninfectious origin. SIRS is nonspecific and can be caused by ischemia, inflammation, trauma, infection, or several indications combined. Infection is a major cause of systemic inflammatory response syndrome; however, a number of other indications, including trauma, ARDS, neoplasm, burn injury, pancreatitis, and dysfunctional macrophage activation are also recognized causes.

In terms of indication, the others segment held a major share of the global systemic inflammatory response syndrome treatment market in 2018. The segment is anticipated to dominate the market during the forecast period, owing to increased penetration.

Request a PDF Sample of Systemic Inflammatory Response Syndrome Treatment Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=73808

Based on end user, the hospitals & ambulatory surgical centers segment is expected to account for a significant share of the global systemic inflammatory response syndrome treatment market. The segment is likely to grow at a rapid pace during the forecast period. The hospitals & ambulatory surgical centers segment is projected to dominate the global market during the forecast period, due to increase in inpatient admissions in hospitals and ambulatory surgical centers. However, limited availability of therapeutics for SIRS and lack of quality care for critically-ill patients are anticipated to hamper the growth of the global SIRS treatment market during the forecast period.

Systemic Inflammatory Response Syndrome Treatment Market: Prominent Regions

North America held a major share of the global systemic inflammatory response syndrome treatment market in 2018. The market in the region is expected to grow at a rapid pace during the forecast period. The market in North America is driven primarily by a rise in the prevalence of SIRS and increase in knowledge about SIRS among healthcare professionals.

Additionally, surge in government initiatives toward infectious & non-infectious diseases, increase in the geriatric population that is at high risk, and a large number of players in North America focusing on R&D activities to introduce technologically-advanced systemic inflammatory response syndrome treatments with improved designs propel the market in the region. The systemic inflammatory response syndrome treatment market in Asia Pacific is likely to witness strong growth. Asia Pacific is a relatively untapped market as compared to developed regions. Hence, the region offers immense opportunities to market players. Rise in the prevalence of SIRS, increase in knowledge about SIRS among healthcare professionals, growth of the healthcare industry, and awareness in the region fuel the growth of the SIRS treatment market in the region.

Europe held the second-largest market share in 2018. Well-developed healthcare infrastructure augments the systemic inflammatory response syndrome treatment market in the region. The markets in the Middle East & Africa and Latin America are projected to witness moderate growth in the near future.

Request for a Discount on Systemic Inflammatory Response Syndrome Treatment Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=73808

Systemic Inflammatory Response Syndrome Treatment Market: Key Players

Key players are expanding their footprint to strengthen their position in the global systemic inflammatory response syndrome treatment market. Developing economies, due to an increase in the number of patient population and surgical procedures, offer lucrative opportunities to key players to increase their market share.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving method-ologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of re-search is the key to help enterprises reach right decision.

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Blog: https://theglobalhealthnews.com/

Author Bio

This user has not submitted a user bio yet

Disqus Comments

Articles Search

Sponsor

Social Media

Forum Threads Search

Pages Search